HomeIPH • EPA
add
Innate Pharma SA
Previous close
€2.19
Day range
€2.19 - €2.23
Year range
€2.11 - €3.35
Market cap
178.30M EUR
Avg Volume
54.82K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 10.72M | 77.43% |
Operating expense | 4.57M | -11.19% |
Net income | -4.64M | 85.58% |
Net profit margin | -43.31 | 91.87% |
Earnings per share | — | — |
EBITDA | -5.20M | 52.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 92.46M | -8.90% |
Total assets | 184.19M | -11.39% |
Total liabilities | 132.29M | -13.94% |
Total equity | 51.90M | — |
Shares outstanding | 80.86M | — |
Price to book | 3.42 | — |
Return on assets | -8.33% | — |
Return on capital | -16.71% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.64M | 85.58% |
Cash from operations | -10.55M | -3.53% |
Cash from investing | 10.44M | 818.88% |
Cash from financing | -360.00K | 17.05% |
Net change in cash | -404.00K | 95.68% |
Free cash flow | -2.80M | 54.44% |
About
Founded
1999
Website
Employees
179